HighTower Advisors’s ARS Pharmaceuticals SPRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $456K | Sell |
26,110
-35
| -0.1% | -$611 | ﹤0.01% | 2595 |
|
|
2025
Q1 | $329K | Sell |
26,145
-965
| -4% | -$12.1K | ﹤0.01% | 2771 |
|
|
2024
Q4 | $286K | Sell |
27,110
-1,200
| -4% | -$12.7K | ﹤0.01% | 2903 |
|
|
2024
Q3 | $411K | Buy |
28,310
+4,369
| +18% | +$63.4K | ﹤0.01% | 2548 |
|
|
2024
Q2 | $204K | Sell |
23,941
-853
| -3% | -$7.27K | ﹤0.01% | 2988 |
|
|
2024
Q1 | $253K | Buy |
24,794
+9,655
| +64% | +$98.5K | ﹤0.01% | 2795 |
|
|
2023
Q4 | $82K | Sell |
15,139
-7,640
| -34% | -$41.4K | ﹤0.01% | 3188 |
|
|
2023
Q3 | $87K | Buy |
22,779
+1,779
| +8% | +$6.8K | ﹤0.01% | 3097 |
|
|
2023
Q2 | $141K | Buy |
21,000
+10,000
| +91% | +$67.1K | ﹤0.01% | 2967 |
|
|
2023
Q1 | $72K | Buy |
+11,000
| New | +$72K | ﹤0.01% | 2957 |
|